Figure 3.
Percentage of subjects with glabellar severity of none or mild post treatment.56
Investigator and subject assessments – Study GL-1; abobotulinumtoxinA, n = 105; placebo, n = 53.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.